AHMED DEWAN

Dr. AHMED DEWAN

orcid
College of Life Sciences, Anhui Agriculture University, Chin...

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AHMED DEWANAHMED DEWAN
AHMED DEWAN
ITIvan Tattoli
Ivan Tattoli
MMMaria Teresa Mascellino
Maria Teresa Mascellino
Fusobacterium nucleatum and activating mutations in the Kirsten rat sarcoma virus oncogene homolog (KRAS) are increasingly recognized as cooperative drivers of colorectal cancer (CRC). F. nucleatum promotes tumorigenesis via adhesion to epithelial cells, modulation of the immune microenvironment, and delivery of virulence factors, while KRAS mutations—present in 60% of CRC cases—amplify proliferative signaling and inflammatory pathways. Here, we review the molecular interplay by which F. nucleatum enhances KRAS-driven oncogenic cascades and, conversely, how KRAS mutations reshape the tumor niche to favor bacterial colonization. We further discuss the use of KRAS as a prognostic biomarker and explore promising non-antibiotic interventions—such as phage therapy, antimicrobial peptides, and targeted small-molecule inhibitors—aimed at selectively disrupting F. nucleatum colonization and virulence. This integrated perspective on microbial–genetic crosstalk offers novel insights for precision prevention and therapy in CRC.

14 November 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
AAAzhaar T. Alsaggaf
Azhaar T. Alsaggaf
MSMostafa Sayed
Mostafa Sayed
AHMED DEWANAHMED DEWAN
AHMED DEWAN
AEAhmed A. El-Rashedy
Ahmed A. El-Rashedy
AEAdel M. Kamal El-Dean
Adel M. Kamal El-Dean
MAMostafa Ahmed
Mostafa Ahmed

17 May 2025 in Journal of Molecular Structure
Verified
Journal Article
Closed access
MGMousa O. Germoush
Mousa O. Germoush
AHMED DEWANAHMED DEWAN
AHMED DEWAN
MFMaged Fouda
Maged Fouda
BABarakat M. Alrashdi
Barakat M. Alrashdi
AEAhmed A. El-Rashedy
Ahmed A. El-Rashedy
MSMostafa Sayed
Mostafa Sayed

24 July 2026 in Journal of Fish Diseases
Verified
Journal Article
Closed access
PDF file
AHMED DEWANAHMED DEWAN
AHMED DEWAN
DGDebora Goulart
Debora Goulart

30 June 2026 in Discover Molecules
Verified
Journal Article
Open access
PDF file
AHMED DEWANAHMED DEWAN
AHMED DEWAN
The global crisis of multidrug-resistant (MDR) bacteria, driven by the overuse and misuse of antibiotics, demands the urgent exploration of effective alternatives. In response, biotics, encompassing probiotics, prebiotics, postbiotics, synbiotics, and bacteriophages—demonstrating 37–40% antibiotic-associated diarrhea (AAD) risk reduction and a 60 - 70% reduction in Clostridioides difficile-associated diarrhea (CDAD) risk reduction—have emerged as a promising and sustainable approach to combat antimicrobial resistance (AMR) by modulating the host-microbiome axis and through competitive exclusion, immunomodulation, and antimicrobial compound production. This review summarizes the current understanding of biotics, focusing on their operational pathways and diverse applications of biotics, particularly within the One Health framework that bridges human, animal, and environmental domains, is crucial. Future research using advanced technologies like Artificial Intelligence (AI) and precision microbiome analysis is expected to unlock the full potential of biotics. This review positions biotics as crucial, targeted, sustainable, and highly effective alternatives to antibiotics while identifying priority areas for future research. Graphical Abstract

Verified
Journal Article
Open access
PDF file
AHMED DEWANAHMED DEWAN
AHMED DEWAN
ITIvan Tattoli
Ivan Tattoli
MMMaria Teresa Mascellino
Maria Teresa Mascellino
The journal retracts the review article titled “The Impact of Fusobacterium nucleatum and the Genotypic Biomarker KRAS on Colorectal Cancer Pathogenesis”